The Piramal Critical Care business of Piramal Healthcare Limited markets a wide range of important hospital and life saving pharmaceuticals which include Inhalation and Intravenous Anaesthetics, Plasma Volume Expanders and Muscle Relaxants. With an aim to emerge as a global leader in this segment, we embarked upon a string of Mergers and

Acquisitions:
Rhodia (Inhalation Anaesthesia Business), UK in FY2005
PlasmaSelect AG (Haemaccel Business), Germany in FY2008
Minrad Inc. and RxElite Holdings, US in FY2009
Bharat Serums and Vaccines Limited (Anaesthesia Business), India in FY 2010
These strategic alliances have been consistent with the objective of recognizing the compelling
potential of our Critical Care business and emerging as a leading player in this segment.

Our Portfolio includes an extensive range of Critical Care products like:

Inhalation Anaesthetics --
Halothane
Sevoflurane (Sojourn™, Petrem™)
Isoflurane (Terrell™, Attane™)
Enflurane (Compound 347™)

Intravenous Anaesthetics --
Propofol (Propovan®)

Regional Anaesthetics --
Bupivacaine (Relicaine™)

Muscle Relaxants --
Atracurium (Atracade™)

Plasma Volume Expanders –
Polygeline (Haemaccel®, Emagel®, Solucel® and Haemageline®)
Our key customers include Group Purchasing Organizations (GPO’s), Human and Veterinary
hospitals, Surgery centres, Anaesthesiologists, Intensivists, University Research centers and
Medical Industrial users.